covid vaccine novavax

Order byBest matchMost fresh

Novavax scores narrower Covid vaccine approval

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

· 5d · on MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

WebMD · 2d

FDA Approves Novavax COVID Vaccine With Restricted Use

· 12h

COVID shots should target newer strains of JN.1 variant in 2025-26 campaign, US FDA advisers say

The House budget bill that narrowly passed in an early morning vote on Thursday would effectively put the brakes on a clean energy production boom in the United States spurred by subsidies enacted in ...

· 17h

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

STAT7h

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to update their vaccines.

1don MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

10hon MSN

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and winter — even as a new Trump administration policy has thrown into question who may be eligible for shots.